How Does SPRINT (Systolic Blood Pressure Intervention Trial) Direct Hypertension Treatment Targets for CKD?

被引：6
|
作者：
Taler, Sandra J. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2016年 / 68卷 / 01期
关键词：
RENAL-DISEASE; NEPHROPATHY; PROGRESSION; IRBESARTAN; OUTCOMES;
D O I：
10.1053/j.ajkd.2016.02.045
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：15 / 18
页数：4
相关论文
共 50 条
  • [41] Efficacy and Safety of Antihypertensive Drug Classes: The Systolic Blood Pressure Intervention Trial (SPRINT)
    Byrne, Christina
    Varshney, Anubodh
    Almarzooq, Zaid
    Kragholm, Kristian H.
    Krogager, Maria L.
    Vaduganathan, Muthiah
    Biering-Srensen, Tor
    Olsen, Michael H.
    Bhatt, Deepak L.
    Pareek, Manan
    CIRCULATION, 2020, 142
  • [42] Impact of Intensive Versus Standard Blood Pressure Management by Tertiles of Blood Pressure in SPRINT (Systolic Blood Pressure Intervention Trial)
    Shapiro, Brian P.
    Ambrosius, Walter T.
    Blackshear, Joseph L.
    Cushman, William C.
    Whelton, Paul K.
    Oparil, Suzanne
    Beddhu, Srinivasan
    Dwyer, Jamie P.
    Gren, Lisa H.
    Kostis, William J.
    Lioudis, Michael
    Pisoni, Roberto
    Rosendorff, Clive
    Haley, William E.
    HYPERTENSION, 2018, 71 (06) : 1064 - 1074
  • [43] Cardiovascular Outcomes in Adults With Systolic Blood Pressure Between 130 and 139 mmHg at Screening in the Systolic Blood Pressure Intervention Trial (SPRINT)
    Contreras, Gabriel
    Lu, Lingyi
    Tamariz, Leonardo
    Rocco, Michael
    Papademetriou, Vasilios
    Kostis, John B.
    Pisoni, Roberto
    Glasser, Stephen P.
    Sweeney, Mary Ellen
    Basile, Jan
    Gren, Lisa H.
    Zamanian, Sara
    Cushman, William C.
    CIRCULATION, 2018, 138
  • [44] Hypertension in Older Adults in the Wake of the Systolic Blood Pressure Intervention Trial
    Rich, Michael W.
    Ouslander, Joseph G.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2018, 66 (04) : 652 - 654
  • [45] Adopting Systolic Pressure Intervention Trial (SPRINT)-like office blood pressure measurements in clinical practice
    Mancia, Giuseppe
    Kjeldsen, Sverre E.
    JOURNAL OF HYPERTENSION, 2017, 35 (03) : 471 - 472
  • [46] Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial
    Still, Carolyn H.
    Rodriguez, Carlos J.
    Wright, Jackson T., Jr.
    Craven, Timothy E.
    Bress, Adam P.
    Chertow, Glenn M.
    Whelton, Paul K.
    Whittle, Jeffrey C.
    Freedman, Barry I.
    Johnson, Karen C.
    Foy, Capri G.
    He, Jiang
    Kostis, John B.
    Lash, James P.
    Pedley, Carolyn F.
    Pisoni, Roberto
    Powell, James R.
    Wall, Barry M.
    AMERICAN JOURNAL OF HYPERTENSION, 2018, 31 (01) : 97 - 107
  • [47] In the Wake of Systolic Blood Pressure Intervention Trial: New Targets for Improving Hypertension Management in Chronic Kidney Disease?
    Tyson, Crystal C.
    Coffman, Thomas M.
    NEPHRON, 2017, 135 (04) : 287 - 290
  • [48] How Low Can You Go? Implications of the Systolic Blood Pressure Intervention Trial for Hypertension Management
    Himmelfarb, Cheryl R. Dennison
    Hayman, Laura L.
    Worel, Jane Nelson
    JOURNAL OF CARDIOVASCULAR NURSING, 2016, 31 (02) : 99 - 100
  • [49] Review of the Systolic Blood Pressure Intervention Trial for Hypertension Management How Low to Go for Patients With Stroke?
    Silver, Brian
    Anderson, Craig S.
    STROKE, 2016, 47 (06) : 1692 - 1694
  • [50] Individualizing treatment choices in the systolic blood pressure intervention trial
    Ferreira, Joao Pedro
    Gregson, John
    Duarte, Kevin
    Gueyffier, Francois
    Rossignol, Patrick
    Zannad, Faiez
    Pocock, Stuart
    JOURNAL OF HYPERTENSION, 2018, 36 (02) : 428 - 435
12345